These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15653411)
1. The role of core antigen detection in management of hepatitis C: a critical review. Seme K; Poljak M; Babic DZ; Mocilnik T; Vince A J Clin Virol; 2005 Feb; 32(2):92-101. PubMed ID: 15653411 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of a total core antigen assay for the diagnosis of hepatitis C virus infection in hemodialysis patients. Bouzgarrou N; Fodha I; Othman SB; Achour A; Grattard F; Trabelsi A; Pozzetto B J Med Virol; 2005 Dec; 77(4):502-8. PubMed ID: 16254976 [TBL] [Abstract][Full Text] [Related]
3. Is an assay for simultaneous detection of hepatitis C virus core antigen and antibody a valuable alternative to nucleic acid testing? Laperche S; Elghouzzi MH; Morel P; Asso-Bonnet M; Le Marrec N; Girault A; Servant-Delmas A; Bouchardeau F; Deschaseaux M; Piquet Y Transfusion; 2005 Dec; 45(12):1965-72. PubMed ID: 16371051 [TBL] [Abstract][Full Text] [Related]
4. Diagnostic algorithm for chronic hepatitis C virus infection: role of the new HCV-core antigen assay. Tillmann HL; Wiegand J; Glomb I; Jelineck A; Picchio G; Wedemeyer H; Manns MP Z Gastroenterol; 2005 Jan; 43(1):11-6. PubMed ID: 15650966 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of a total hepatitis C virus (HCV) core antigen assay for the detection of antigenaemia in anti-HCV positive individuals. Valcavi P; Medici MC; Casula F; Arcangeletti MC; De Conto F; Pinardi F; Calderaro A; Chezzi C; Dettori G J Med Virol; 2004 Jul; 73(3):397-403. PubMed ID: 15170635 [TBL] [Abstract][Full Text] [Related]
6. Performance of ORTHO HCV core antigen and trak-C assays for detection of viraemia in pre-seroconversion plasma and whole blood donors. Tobler LH; Stramer SL; Lee SR; Baggett D; Wright D; Hirschkorn D; Walsh I; Busch MP Vox Sang; 2005 Nov; 89(4):201-7. PubMed ID: 16262752 [TBL] [Abstract][Full Text] [Related]
7. Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replication. Bouvier-Alias M; Patel K; Dahari H; Beaucourt S; Larderie P; Blatt L; Hezode C; Picchio G; Dhumeaux D; Neumann AU; McHutchison JG; Pawlotsky JM Hepatology; 2002 Jul; 36(1):211-8. PubMed ID: 12085367 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA. Tanaka E; Ohue C; Aoyagi K; Yamaguchi K; Yagi S; Kiyosawa K; Alter HJ Hepatology; 2000 Aug; 32(2):388-93. PubMed ID: 10915747 [TBL] [Abstract][Full Text] [Related]
9. [Clinical benefit of HCV core antigen assay in patients receiving interferon and ribavirin combination therapy]. Higashimoto M; Takahashi M; Jokyu R; Saito H Rinsho Byori; 2006 Feb; 54(2):111-5. PubMed ID: 16548229 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance and problems in HCV measurement--comparison of CLEIA method with PCR method]. Ohta H; Takemura M; Furuta N; Akiyama M; Katagiri Y; Ohashi H; Takahashi K; Saito K; Seishima M Rinsho Byori; 2004 Oct; 52(10):813-8. PubMed ID: 15624496 [TBL] [Abstract][Full Text] [Related]
11. Reliability of hepatitis C virus core antigen assay for detection of viremia in HCV genotypes 1, 2, 3, and 4 infected blood donors: a collaborative study between Japan, Egypt, and Uzbekistan. Agha S; Tanaka Y; Saudy N; Kurbanov F; Abo-Zeid M; El-Malky M; Khalaf M; Ohta N; Yoshizawa H; Mizokami M J Med Virol; 2004 Jun; 73(2):216-22. PubMed ID: 15122795 [TBL] [Abstract][Full Text] [Related]
12. Simultaneous detection of hepatitis C virus core antigen and antibodies in Saudi drug users using a novel assay. Alzahrani AJ J Med Virol; 2008 Apr; 80(4):603-6. PubMed ID: 18297713 [TBL] [Abstract][Full Text] [Related]
13. Hepatitis C virus window-phase infections: closing the window on hepatitis C virus. Tuke PW; Grant PR; Waite J; Kitchen AD; Eglin RP; Tedder RS Transfusion; 2008 Apr; 48(4):594-600. PubMed ID: 18194388 [TBL] [Abstract][Full Text] [Related]
14. [Early detection of hepatitis C virus infection using a new combined antigen-antibody detection assay: potential use in HIV co-infected individuals]. Schnuriger A; Dominguez S; Valantin MA; Tubiana R; Duvivier C; Ghosn J; Simon A; Katlama C; Thibault V Pathol Biol (Paris); 2006 Dec; 54(10):578-86. PubMed ID: 17030457 [TBL] [Abstract][Full Text] [Related]
15. Application of the trak-C HCV core assay for monitoring antiviral activity in HCV replication systems. Cagnon L; Wagaman P; Bartenschlager R; Pietschmann T; Gao T; Kneteman NM; Tyrrell DL; Bahl C; Niven P; Lee S; Simmen KA J Virol Methods; 2004 Jun; 118(1):23-31. PubMed ID: 15158065 [TBL] [Abstract][Full Text] [Related]
16. Quantitative determination of hepatitis C core antigen in therapy monitoring for chronic hepatitis C. Moscato GA; Giannelli G; Grandi B; Pieri D; Marsi O; Guarducci I; Batini I; Altomare E; Antonaci S; Capria A; Pellegrini G; Sacco R Intervirology; 2011 Feb; 54(2):61-5. PubMed ID: 20829601 [TBL] [Abstract][Full Text] [Related]
17. A chemiluminescent, magnetic particle-based immunoassay for the detection of hepatitis C virus core antigen in human serum or plasma. Leary TP; Gutierrez RA; Muerhoff AS; Birkenmeyer LG; Desai SM; Dawson GJ J Med Virol; 2006 Nov; 78(11):1436-40. PubMed ID: 16998880 [TBL] [Abstract][Full Text] [Related]
18. Total HCV core antigen assay. A new marker of HCV viremia and its application during treatment of chronic hepatitis C. Lorenzo J; Castro A; Aguilera A; Prieto E; López-Calvo S; Regueiro B; Pedreira J J Virol Methods; 2004 Sep; 120(2):173-7. PubMed ID: 15288960 [TBL] [Abstract][Full Text] [Related]
19. Accuracy of hepatitis C virus core antigen testing in pools among seroconverters. Beer N; Shinar E; Novack L; Safi J; Soliman H; Yaari A; Goldman-Levi R; Yahalom V; Bolotin A; Sarov B Transfusion; 2006 Oct; 46(10):1822-8. PubMed ID: 17002640 [TBL] [Abstract][Full Text] [Related]
20. Modulation of epitope-specific anti-hepatitis C virus E2 (anti-HCV/E2) antibodies by anti-viral treatment. Mancini N; Carletti S; Perotti M; Romanò L; Craxì RD; Craxì A; Zanetti AR; Clementi M; Burioni R J Med Virol; 2006 Oct; 78(10):1304-11. PubMed ID: 16927283 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]